← The Wire
RFLNYSE
Rafael Holdings, Inc.
Pharmaceutical Preparations · DE · CIK 1713863
Develops pharmaceuticals and holds interests in companies developing pharmaceuticals and medical devices
$116M
Market cap
$3.16
Last close
+14.5%
1D
+14.9%
5D
333K
Volume
Price · last 39 sessions+152.8%
May 4L $1.25 · H $3.16Jun 29
170
Total filings
Jun 11, 2026
Last filing
07/31
Fiscal year end
10-QQUARTERLY REPORTJun 11, 20268-KResults of OperationsJun 11, 20268-KReg FD Disclosure · Company UpdateJun 10, 20268-KReg FD Disclosure · Company UpdateApr 22, 202610-QQUARTERLY REPORTMar 16, 20268-KResults of OperationsMar 16, 20268-KShareholder VoteJan 12, 202610-QQUARTERLY REPORTDec 12, 20258-KResults of OperationsDec 11, 20258-KCompany UpdateDec 2, 2025DEF 14APROXY STATEMENTNov 18, 202510-KANNUAL REPORTOct 29, 20258-KResults of OperationsOct 29, 20258-KExecutive ChangeOct 28, 20258-KReg FD DisclosureOct 10, 20258-KExecutive ChangeAug 7, 20258-KExecutive Change · Bylaw AmendmentJul 18, 20258-KReg FD Disclosure · Company UpdateJun 18, 202510-QQUARTERLY REPORTJun 11, 20258-KResults of OperationsJun 11, 20258-KEquity Issuance · Company UpdateJun 4, 20258-K/ACompany UpdateMay 20, 20258-KMaterial Agreement · Equity IssuanceMay 6, 20258-K/ACompany UpdateMay 5, 20258-KCompany UpdateApr 29, 20258-K/ACompany UpdateApr 28, 20258-KExecutive ChangeApr 24, 20258-KExecutive Change · Acquisition / DispositionMar 26, 20258-KShareholder VoteMar 25, 202510-QQUARTERLY REPORTMar 14, 20258-KResults of OperationsMar 14, 20258-KMaterial AgreementFeb 10, 20258-KShareholder VoteJan 13, 202510-K/AAMENDMENT NO. 2 TO FORM 10-KJan 8, 20258-KCompany UpdateDec 23, 202410-K/AAMENDMENT NO. 1 TO FORM 10-KDec 20, 202410-QQUARTERLY REPORTDec 11, 20248-KResults of OperationsDec 11, 2024DEF 14APROXY STATEMENTNov 19, 202410-KANNUAL REPORTNov 7, 20248-KResults of OperationsNov 7, 2024S-4REGISTRATION STATEMENTOct 9, 2024425CURRENT REPORTAug 22, 20248-KMaterial Agreement · New Debt / ObligationAug 22, 20248-KExecutive ChangeAug 8, 202410-QQUARTERLY REPORTJun 14, 20248-KResults of OperationsJun 14, 20248-K/ACompany UpdateMay 23, 202410-QQUARTERLY REPORTMar 14, 20248-KResults of OperationsMar 14, 20248-KAcquisition / DispositionMar 13, 20248-KShareholder VoteJan 16, 202410-QQUARTERLY REPORTDec 14, 20238-KResults of OperationsDec 14, 2023DEF 14APROXY STATEMENTNov 20, 202310-KANNUAL REPORTOct 30, 20238-KResults of OperationsOct 30, 20238-KExecutive ChangeOct 26, 20238-KExecutive ChangeAug 9, 20238-K/ACompany UpdateAug 2, 20238-KChange of ControlAug 2, 202310-QQUARTERLY REPORTJun 13, 20238-KResults of OperationsJun 13, 20238-KCompany UpdateJun 5, 2023SC 13DSCHEDULE 13DMay 11, 20238-KReg FD Disclosure · Company UpdateApr 4, 202310-QQUARTERLY REPORTMar 14, 20238-KResults of OperationsMar 14, 20238-KExecutive ChangeFeb 2, 20238-KShareholder VoteJan 26, 20238-KExecutive ChangeJan 5, 202310-QQUARTERLY REPORTDec 13, 20228-KResults of OperationsDec 13, 2022DEF 14ADEFINITIVE PROXY STATEMENTNov 28, 20228-KExit / Disposal Costs · Reg FD DisclosureNov 15, 202210-KANNUAL REPORTOct 31, 20228-KResults of OperationsOct 31, 20228-K/ACompany UpdateAug 26, 20228-KAcquisition / DispositionAug 23, 20228-K/AMaterial AgreementAug 1, 2022
Similar companies
Comparable business profile · signals at a glance